Sequent is down 60% from its highs. Let's understand how their business is faring (by @AnishA_Moonka )

A thread 🧵👇

1/ How do businesses happen? Do they just crop up the day when an entrepreneur thinks of it? Do they become bigger as the stock reaches new highs?

I guess, No. It takes time, It takes labor. Again, Will the ascension be smooth? Never.

The journey of Sequent in the last 5 yrs:
2/ Pre-FY15: Sequent was merely a commodity high volume low-value API player

Due to this intrapreneur's (Mr. Manish Gupta) efforts that we see Sequent as the only USFDA approved generic animal player from 🇮🇳

Behind the deals of Strides Agila plant & the Australian business.
3/ The transformation speaks volumes of how such a businessman thinks.

In 6yrs of existence, he has taken the unknown co. to be among the Top 20 in the world.

Now, he is taking a long shot to enter the Top 10 over the next decade (aka. Sequent 2.0); A tall task.
4/ If he is dreaming big & has executed in the past with industry tailwinds; the common question is why is the stock down by so much?

Probabilities: Investors went from a high probability of success to a low in months as multiple obstacles (short term?) hit the co.
5/ Again, It's not all hunky Dory.

While the rev growth is better than the industry, the co. has been struggling with margins for the last 2-3 quarters.

There are multiple obstacles & we will discuss them one by one.
6/ This quarter the gross margins have dropped to a 5yr low of 42.8%.

Particularly, the China power issue again (as I had discussed in my Laurus thread)

A sharp rise in input costs & given a B2B company; passing on takes a long time & is usually a difficult conversation.
7/ While it is visible that China+1 is playing out in the broad sense; the dependence on our neighbors is not going anytime soon, at least not for 2-3yrs

Such disruptions are a risk. Also, Higher inventories are an outcome (Higher Working capital)

Anyway, it will get passed on.
8/ Another risk that played out was of much lower orders in the API business especially Albendazole.

While the portfolio continues to grow in number & rev (up 25% in Q2FY22); the albendazole API degree by a lot leading to 10% regrowth overall

Stockpiling last year, hurt them.
9/ The biggest risk remains the Turkish Lira devaluation: Not even a forex expert knows

Sequent does get the benefit of a weaker currency to export (use Turkey as its supply base); however, the Turkey domestic biz gets hurt: In Q2 they grew 11% in cc but degree 7% in real terms.
10/ However, let's talk positives now

- Big Opportunity: $51B industry globally growing at 5-6% cagr
- Strong R&D efforts (Formulations & APIs) to drive the next leg of growth
- Major capacity expansion over FY22-23: focused on regulated markets
11/ - Top industry veterans induced into the board in the last year with a focus toward maximizing the Terminal value
- Optionality: CDMO & CMO contracts with Top 10 global Animal Healthcare cos.
- Capacity to suffer: Investing 200crs over the next 2 yrs in capability building.
12/ To summarise, there are multiple strands one can write on this niche industry with very strong economics once scale is reached. Think Zoetis.

However, I aspired to just clarify the misinterpretations. Let me know in the comments about your thoughts on Sequent 2.0 😸

End.
If you found the thread to be of help, please retweet the 1st tweet 👇 to help us educate more investors.
https://t.co/MP3T5Gepm6

More from JST Investments

You May Also Like

A THREAD ON @SarangSood

Decoded his way of analysis/logics for everyone to easily understand.

Have covered:
1. Analysis of volatility, how to foresee/signs.
2. Workbook
3. When to sell options
4. Diff category of days
5. How movement of option prices tell us what will happen

1. Keeps following volatility super closely.

Makes 7-8 different strategies to give him a sense of what's going on.

Whichever gives highest profit he trades in.


2. Theta falls when market moves.
Falls where market is headed towards not on our original position.


3. If you're an options seller then sell only when volatility is dropping, there is a high probability of you making the right trade and getting profit as a result

He believes in a market operator, if market mover sells volatility Sarang Sir joins him.


4. Theta decay vs Fall in vega

Sell when Vega is falling rather than for theta decay. You won't be trapped and higher probability of making profit.
1

From today, we will memorize the names of 27 Nakshatras in Vedic Jyotish to never forget in life.

I will write 4 names. Repeat them in SAME sequence twice in morning, noon, evening. Each day, revise new names + recall all previously learnt names.

Pls RT if you are in.

2

Today's Nakshatras are:-

1. Ashwini - अश्विनी

2. Bharani - भरणी

3. Krittika - कृत्तिका

4. Rohini - रोहिणी

Ashwini - अश्विनी is the FIRST Nakshatra.

Repeat these names TWICE now, tomorrow morning, noon and evening. Like this tweet if you have revised 8 times as told.

3

Today's Nakshatras are:-

5. Mrigashira - मृगशिरा

6. Ardra - आर्द्रा

7. Punarvasu - पुनर्वसु

8. Pushya - पुष्य

First recall previously learnt Nakshatras twice. Then recite these TWICE now, tomorrow morning, noon & evening in SAME order. Like this tweet only after doing so.

4

Today's Nakshatras are:-

9. Ashlesha - अश्लेषा

10. Magha - मघा

11. Purvaphalguni - पूर्वाफाल्गुनी

12. Uttaraphalguni - उत्तराफाल्गुनी

Purva means that comes before (P se Purva, P se pehele), and Uttara comes later.

Read next tweet too.

5

Purva, Uttara prefixes come in other Nakshatras too. Purva= pehele wala. Remember.

First recall previously learnt 8 Nakshatras twice. Then recite those in Tweet #4 TWICE now, tomorrow morning, noon & evening in SAME order. Like this tweet if you have read Tweets #4 & 5, both.